Quantbot Technologies’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,805
| Closed | -$133K | – | 2021 |
|
|
2025
Q4 | $133K | Buy |
+14,805
| New | +$204K | ﹤0.01% | 1348 |
|
|
2025
Q2 | – | Sell |
-6,663
| Closed | -$47.4K | – | 1846 |
|
|
2025
Q1 | $47.4K | Buy |
6,663
+5,959
| +846% | +$60.2K | ﹤0.01% | 1328 |
|
|
2024
Q4 | $8.21K | Buy |
+704
| New | +$11K | ﹤0.01% | 1380 |
|
|
2022
Q4 | – | Sell |
-1,428
| Closed | -$79K | – | 1975 |
|
|
2022
Q3 | $79K | Sell |
1,428
-7,185
| -83% | -$446K | 0.01% | 1161 |
|
|
2022
Q2 | $445K | Buy |
+8,613
| New | +$437K | 0.04% | 613 |
|
|
2021
Q4 | – | Sell |
-3,380
| Closed | -$453K | – | 1770 |
|
|
2021
Q3 | $453K | Buy |
+3,380
| New | +$512K | 0.03% | 635 |
|
|
2021
Q1 | – | Sell |
-454
| Closed | -$24K | – | 1655 |
|
|
2020
Q4 | $24K | Buy |
+454
| New | +$16.5K | ﹤0.01% | 986 |
|
|
2020
Q2 | – | Sell |
-20
| Closed | – | – | 1346 |
|
|
2020
Q1 | $0 | Sell |
20
-3,739
| -99% | -$50.4K | ﹤0.01% | 1230 |
|
|
2019
Q4 | $55K | Sell |
3,759
-1,681
| -31% | -$23.4K | 0.01% | 940 |
|
|
2019
Q3 | $72K | Buy |
5,440
+4,440
| +444% | +$70.8K | 0.01% | 904 |
|
|
2019
Q2 | $16K | Buy |
+1,000
| New | +$15.7K | ﹤0.01% | 1061 |
|
|
2018
Q3 | – | Sell |
-1,506
| Closed | -$41K | – | 1457 |
|
|
2018
Q2 | $41K | Buy |
1,506
+220
| +17% | +$5.33K | ﹤0.01% | 1023 |
|
|
2018
Q1 | $27K | Buy |
1,286
+296
| +30% | +$7.28K | ﹤0.01% | 1044 |
|
|
2017
Q4 | $19K | Buy |
+990
| New | +$22.9K | ﹤0.01% | 1075 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP